First-in-Class Research That Fuels Life-Changing Advancements in Uro-Oncology

Ferring Uro-Oncology links arms with scientists, the healthcare community and advocacy groups to create meaningful innovations for people facing urological cancers.

Our leadership is defined by a determination to recognize and solve unmet patient needs. We commit to this with exhaustive research, a robust clinical development program and strong alliances with thought leaders and advocacy groups.

Together, we advance science to truly improve lives by transforming the patient experience and the treatment landscape.

Scientist taking notes
Family planting a tree

Our Commitment

Excellence in All Aspects of Innovation to Create Solutions for Patients Now and in the Future

Keeping Patients at the Center

Patient needs are at the heart of our research. Ferring Uro-Oncology has an unwavering commitment to uncovering insights for a deeper understanding of unmet needs in order to create meaningful progress and positive outcomes for people with urological cancers.

Pioneering Innovation in Uro-Oncology Research

Ferring Uro-Oncology strives to optimize treatment paradigms and the patient experience. We are committed to an expanded clinical development program, exploring new combination therapies and developing innovative medicines for new indications.

Investing in Manufacturing to Meet Future Growth

With a history of significant investment in manufacturing capabilities, Ferring Uro-Oncology continues to upgrade and increase production to satisfy demand. We are firmly positioned to meet current and future clinical needs.

Partnering With the Community

Working with leading voices in the uro-oncology community, Ferring Uro-Oncology creates meaningful collaborations to further science while helping to provide hope to patients and their families.

Ground-Breaking Research Driven by Life-Transforming Science

Ferring Uro-Oncology recognizes that all patients have the right to live their best and healthiest life possible. This knowledge is foremost in the minds of our researchers and drives them in a tireless pursuit of meaningful innovation. Novel treatments are the result of novel thinking that equally solves for the human condition and the mechanism of disease.

Reigniting Hope in the Face of Bladder Cancer

Non-muscle invasive bladder cancer is the most common type of bladder cancer. With incidence increasing, research is galvanized to address the growing needs in this patient community.

Learn More

Tackling the Second-Leading Cause of Cancer Death in Men

It’s estimated that 20% of men in the US will develop prostate cancer. Increased testing and addressing the drivers of progression are key to changing the statistics.

Learn More

Learn more about an innovative treatment for non-muscle invasive bladder cancer (NMIBC).

Partnering Organization

Ferring Uro-Oncology is proud to partner with organizations who tirelessly advocate for patients’ needs. Through their thoughtful collaboration, we gain insights that ultimately help deliver resources to create a better world for people diagnosed with urological cancer and their families.

Keep Up With the Latest Advancements

Press Release Icon

US Press Releases

Global Press Release Icon

Global Press Releases

Company Statement Icon

Company Statements